Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology

Analytical Chemistry

Volumn 85, Issue 19, 2013, Pages 9390-9399

  Patton, Amy L ^a   Seely, Kathryn A ^a   Chimalakonda, Krishna C ^b   Tran, Johnny P ^a   Trass, Matthew ^c   Miranda, Art ^c   Fantegrossi, William E ^b   Kennedy, Paul D ^f   Dobrowolski, Paul ^f   Radominska Pandya, Anna ^b   McCain, Keith R ^d   James, Laura P ^e   Endres, Gregory W ^f   Moran, Jeffery H ^a,b  

^a ARKANSAS DEPARTMENT OF HEALTH   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Phenomenex   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e ARKANSAS CHILDREN S HOSPITAL   (United States)

^f Cayman Chemical Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENANTIOSPECIFICITY; HUMAN URINE SAMPLES; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROSCOPIES; PHARMACOKINETIC PROPERTIES; RELATIVE ABUNDANCE; STRONG CORRELATION; SYNTHETIC CANNABINOID; SYNTHETIC CANNABINOIDS;

BODY FLUIDS; ENANTIOMERS; GLUCOSE; LIQUID CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY; METABOLISM; METABOLITES; ORGANIC POLYMERS; PHYSIOLOGY; TOXICITY;

BIOMOLECULES;

1 (5 FLUOROPENTYL) 3 (1 NAPHTHOYL)INDOLE; 1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE; 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; INDOLE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; HUMAN; LIQUID CHROMATOGRAPHY; METABOLISM; METABOLOMICS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; URINE;

CHROMATOGRAPHY, LIQUID; HUMANS; INDOLES; METABOLOMICS; MOLECULAR STRUCTURE; NAPHTHALENES; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 84884993702     PISSN: 00032700     EISSN: 15206882     Source Type: Journal    
DOI: 10.1021/ac4024704     Document Type: Article

References (46)

1. Eggan, S. M.; Lewis, D. A. Cereb. Cortex 2007, 17, 175-191
2. Gaoni, Y.; Mechoulam, R. J. Am. Chem. Soc. 1964, 86, 1646-1647
3. Howlett, A. C.; Breivogel, C. S.; Childers, S. R.; Deadwyler, S. A.; Hampson, R. E.; Porrino, L. J. Neuropharmacology 2004, 47 (Suppl 1) 345-358
4. Devane, W. A.; Dysarz, F. A., III; Johnson, M. R.; Melvin, L. S.; Howlett, A. C. Mol. Pharmacol. 1988, 34, 605-613
5. Lee, H. K.; Choi, E. B.; Pak, C. S. Curr. Top. Med. Chem. 2009, 9, 482-503
6. Turcotte, D.; Le Dorze, J. A.; Esfahani, F.; Frost, E.; Gomori, A.; Namaka, M. Expert Opin. Pharmacother. 2010, 11, 17-31
7. Vemuri, V. K.; Janero, D. R.; Makriyannis, A. Physiol. Behav. 2008, 93, 671-686
8. Graham, E. S.; Ashton, J. C.; Glass, M. Front. Biosci. 2009, 14, 944-957
9. Pertwee, R. G. Br. J. Pharmacol. 2009, 156, 397-411
10. Aggarwal, S. K.; Carter, G. T.; Sullivan, M. D.; ZumBrunnen, C.; Morrill, R.; Mayer, J. D. J. Opioid Manage. 2009, 5, 153-168
11. Moreira, F. A.; Grieb, M.; Lutz, B. Best Pract. Res., Clin. Endocrinol. Metab. 2009, 23, 133-144
12. EMCDDA. Spice and Related Synthetic Cannabinoids; European Monitoring Centre for Drugs and Drug Addiction: Lisbon, Portugal, 2009.
13. Vandrey, R.; Dunn, K. E.; Fry, J. A.; Girling, E. R. Drug Alcohol Depend. 2012, 120, 238-241
14. Muller, H.; Sperling, W.; Kohrmann, M.; Huttner, H. B.; Kornhuber, J.; Maler, J. M. Schizophr. Res. Treat. 2010, 118, 309-310
15. Vearrier, D.; Osterhoudt, K. C. Pediatr. Emerg. Care 2010, 26, 462-465
16. Every-Palmer, S. Drug Alcohol Depend. 2011, 117, 152-157
17. Every-Palmer, S. Addiction 2010, 105, 1859-1860
18. Schneir, A. B.; Cullen, J.; Ly, B. T. J. Emerg. Med. 2010, 40, 296-299
19. Lapoint, J.; James, L. P.; Moran, C. L.; Nelson, L. S.; Hoffman, R. S.; Moran, J. H. Clin. Toxicol. 2011, 49, 760-764
20. Simmons, J. R.; Skinner, C. G.; Williams, J.; Kang, C. S.; Schwartz, M. D.; Wills, B. K. Ann. Emerg. Med. 2011, 57, 187-188
21. Young, A. C.; Schwarz, E.; Medina, G.; Obafemi, A.; Feng, S. Y.; Kane, C.; Kleinschmidt, K. Am. J. Emerg. Med. 2011, 30, 1320.e5-1320.e7
22. Gunderson, E. W.; Haughey, H. M.; Ait-Daoud, N.; Joshi, A. S.; Hart, C. L. Am. J. Addict. 2012, 21, 320-326
23. Mir, A.; Obafemi, A.; Young, A.; Kane, C. Pediatrics 2011, 128, e1622-e1627
24. Simmons, J.; Cookman, L.; Kang, C.; Skinner, C. Clin. Toxicol. 2011, 49, 431-433
25. Tofighi, B.; Lee, J. D. J. Addict. Med. 2012, 6, 240-241
26. Patton, A. L.; Chimalakonda, K. C.; Moran, C. L.; McCain, K.; Radominska-Pandya, A.; James, L.; Moran, J. H. J. Forensic Sci. 2013, epub ahead of print
27. Wells, D. L.; Ott, C. A. Ann. Pharmacother. 2011, 45, 414-417
28. Fattore, L.; Fratta, W. Front. Behav. Neurosci. 2011, 5, 60
29. Brents, L. K.; Gallus-Zawada, A.; Radominska-Pandya, A.; Vasiljevik, T.; Prisinzano, T. E.; Fantegrossi, W. E.; Moran, J. H.; Prather, P. L. Biochem. Pharmacol. 2012, 83, 952-961
30. Brents, L. K.; Reichard, E. E.; Zimmerman, S. M.; Moran, J. H.; Fantegrossi, W. E.; Prather, P. L. PLoS One 2011, 6, e21917
31. Seely, K. A.; Brents, L. K.; Radominska-Pandya, A.; Endres, G. W.; Keyes, G. S.; Moran, J. H.; Prather, P. L. Chem. Res. Toxicol. 2012, 25, 825-827
32. Chimalakonda, K. C.; Seely, K. A.; Bratton, S. M.; Brents, L. K.; Moran, C. L.; Endres, G. W.; James, L. P.; Hollenberg, P. F.; Prather, P. L.; Radominska-Pandya, A.; Moran, J. H. Drug Metab. Dispos. 2012, 40, 2174-2184
33. Wintermeyer, A.; Möller, I.; Thevis, M.; Jübner, M.; Beike, J.; Rothschild, M.; Bender, K. Anal. Biol. Chem. 2010, 398, 2141-2153
34. Gronewold, A.; Skopp, G. Forensic Sci. Int. 2011, 210, e7-e11
35. Chimalakonda, K. C.; Moran, C. L.; Kennedy, P. D.; Endres, G. W.; Uzieblo, A.; Dobrowolski, P. J.; Fifer, E. K.; Lapoint, J.; Nelson, L. S.; Hoffman, R. S.; James, L. P.; Radominska-Pandya, A.; Moran, J. H. Anal. Chem. 2011, 83, 6381-6388
36. Moran, C. L.; Le, V. H.; Chimalakonda, K. C.; Smedley, A. L.; Lackey, F. D.; Owen, S. N.; Kennedy, P. D.; Endres, G. W.; Ciske, F. L.; Kramer, J. B.; Kornilov, A. M.; Bratton, L. D.; Dobrowolski, P. J.; Wessinger, W. D.; Fantegrossi, W. E.; Prather, P. L.; James, L. P.; Radominska-Pandya, A.; Moran, J. H. Anal. Chem. 2011, 83, 4228-4236
37. Chimalakonda, K. C.; Bratton, S. M.; Le, V. H.; Yiew, K. H.; Dineva, A.; Moran, C. L.; James, L. P.; Moran, J. H.; Radominska-Pandya, A. Drug Metab. Dispos. 2011, 39, 1967-1976
38. Hruba, L.; Ginsburg, B. C.; McMahon, L. R. J. Pharmacol. Exp. Ther. 2012, 342, 843-849
39. Ginsburg, B. C.; Schulze, D. R.; Hruba, L.; McMahon, L. R. J. Pharmacol. Exp. Ther. 2012, 340, 37-45
40. Wohlfarth, A.; Scheidweiler, K. B.; Chen, X.; Liu, H. F.; Huestis, M. A. Anal. Chem. 2013, 85, 3730-3738
41. Hutter, M.; Broecker, S.; Kneisel, S.; Auwarter, V. J. Mass Spectrom. 2012, 47, 54-65
42. Bratton, S. M.; Mosher, C. M.; Khallouki, F.; Finel, M.; Court, M. H.; Moran, J. H.; Radominska-Pandya, A. J. Pharmacol. Exp. Ther. 2011, 340, 46-55
43. Haritos, V. S.; Ghabrial, H.; Ahokas, J. T.; Ching, M. S. Pharmacogenetics 2000, 10, 591-603
44. Roy, P.; Tretyakov, O.; Wright, J.; Waxman, D. J. Drug Metab. Dispos. 1999, 27, 1309-1318
45. Campo, V. L.; Bernardes, L. S.; Carvalho, I. Curr. Drug Metab. 2009, 10, 188-205
46. Brocks, D. R. Biopharm. Drug Dispos. 2006, 27, 387-406